Omicia | GenomeWeb

Omicia

The institute recently launched rapid genome sequencing for critically ill newborns and plans to test genomic sequencing in several programs and clinical trials.

The institute will use Omicia's Opal Clinical system to achieve its goal of a 24-hour turnaround time for large-scale genome testing in its intensive care units.

Omicia will use the proceeds to accelerate product development, expand sales and marketing, and extend variations of its flagship Opal Clinical platform for NGS data analysis.

Congenica and Omicia have signed contracts to interpret data from the first 8,000 patients in the UK's 100,000 Genomes Project.

Genomics England has selected Congenica, Omicia, NantHealth, and WuXi Nextcode to provide clinical interpretation services for rare diseases and cancer

The company makes tests with rapid time-to-results intended for high-volume hospital and pathology labs using its proprietary diagnostic technology, 3Base.

NEW YORK (GenomeWeb) – Seattle-based Spiral Genetics has shifted the focus of its business from building solutions based on existing open source software for genomic data analysis, to developing a suite of products based on a proprietary method of detecting large structural changes in the genome.

Bioarray of Elche, Spain, has launched a preimplantation genetic screening service of embryos using next-generation sequencing. According to the company, using NGS for PGS is less expensive than older techniques and can be combined with preimplantation genetic diagnosis.

Cypher Genomics said this week that it is offering trial access to Mantis, its genome interpretation technology through a newly launched program called Mantis 5-for-5.

This week, GenomeQuest launched a new Intellectual Property Management module for its software that lets customers manage their sequence IP.

Pages

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.